Cover Image

Medicine Pricing Policies: The Impact On Availability And Affordability In Four Provinces In Indonesia

The government of Indonesia has established a commitment to the provision of affordable medicines. The retail price of unbranded generic cannot exceed the maximum retail price set by the Ministry of Health. The generic medicine pricing policy that has been implemented by the Indonesian government mu...

Full description

Saved in:
Bibliographic Details
Main Author: Anggriani, Yusi
Format: Thesis
Language:English
Published: 2013
Subjects:
RS1-441 Pharmacy and materia medica
Online Access:http://eprints.usm.my/50167/1/Yusi%20Anggriani24.pdf
http://eprints.usm.my/50167/
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.usm.eprints.50167
record_format eprints
spelling my.usm.eprints.50167 http://eprints.usm.my/50167/ Medicine Pricing Policies: The Impact On Availability And Affordability In Four Provinces In Indonesia Anggriani, Yusi RS1-441 Pharmacy and materia medica The government of Indonesia has established a commitment to the provision of affordable medicines. The retail price of unbranded generic cannot exceed the maximum retail price set by the Ministry of Health. The generic medicine pricing policy that has been implemented by the Indonesian government must be evaluated. The objectives of this study were to evaluate the impact on the price, availability and affordability of selected medicines and to evaluate the context, process, evidence and links of generic medicine pricing policies development in Indonesia. The first part of the study was conducted using a standardized methodology developed by the World Health Organization and Health Action International. The prices, availability and affordability of 50 medicines were measured at public, private and NGO facilities in four provinces in Indonesia (Sumatera Selatan, Jakarta, Yogyakarta and Sulawesi Selatan). The type of medicines selected were Lowest Price Generics (LPGs) and Innovator Brands (IBs). The 2009 International Reference Price (IRP) was used to calculate the median price ratio (MPR). The second part of the study was conducted using the following methods: a review of medicine pricing policies documents, in-depth interviews with 10 key informants and 10 observations of meetings about medicine prices. Transcripts were generated and analyzed using qualitative content analysis. 2013-02 Thesis NonPeerReviewed application/pdf en http://eprints.usm.my/50167/1/Yusi%20Anggriani24.pdf Anggriani, Yusi (2013) Medicine Pricing Policies: The Impact On Availability And Affordability In Four Provinces In Indonesia. PhD thesis, Universiti Sains Malaysia.
institution Universiti Sains Malaysia
building Hamzah Sendut Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Sains Malaysia
content_source USM Institutional Repository
url_provider http://eprints.usm.my/
language English
topic RS1-441 Pharmacy and materia medica
spellingShingle RS1-441 Pharmacy and materia medica
Anggriani, Yusi
Medicine Pricing Policies: The Impact On Availability And Affordability In Four Provinces In Indonesia
description The government of Indonesia has established a commitment to the provision of affordable medicines. The retail price of unbranded generic cannot exceed the maximum retail price set by the Ministry of Health. The generic medicine pricing policy that has been implemented by the Indonesian government must be evaluated. The objectives of this study were to evaluate the impact on the price, availability and affordability of selected medicines and to evaluate the context, process, evidence and links of generic medicine pricing policies development in Indonesia. The first part of the study was conducted using a standardized methodology developed by the World Health Organization and Health Action International. The prices, availability and affordability of 50 medicines were measured at public, private and NGO facilities in four provinces in Indonesia (Sumatera Selatan, Jakarta, Yogyakarta and Sulawesi Selatan). The type of medicines selected were Lowest Price Generics (LPGs) and Innovator Brands (IBs). The 2009 International Reference Price (IRP) was used to calculate the median price ratio (MPR). The second part of the study was conducted using the following methods: a review of medicine pricing policies documents, in-depth interviews with 10 key informants and 10 observations of meetings about medicine prices. Transcripts were generated and analyzed using qualitative content analysis.
format Thesis
author Anggriani, Yusi
author_facet Anggriani, Yusi
author_sort Anggriani, Yusi
title Medicine Pricing Policies: The Impact On Availability And Affordability In Four Provinces In Indonesia
title_short Medicine Pricing Policies: The Impact On Availability And Affordability In Four Provinces In Indonesia
title_full Medicine Pricing Policies: The Impact On Availability And Affordability In Four Provinces In Indonesia
title_fullStr Medicine Pricing Policies: The Impact On Availability And Affordability In Four Provinces In Indonesia
title_full_unstemmed Medicine Pricing Policies: The Impact On Availability And Affordability In Four Provinces In Indonesia
title_sort medicine pricing policies: the impact on availability and affordability in four provinces in indonesia
publishDate 2013
url http://eprints.usm.my/50167/1/Yusi%20Anggriani24.pdf
http://eprints.usm.my/50167/
_version_ 1713200643397648384
score 13.211869

Similar Items